EUVIMEDEUVIMED entdecken
Beobachtungsstudie

The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients

Adina R Kern-Goldberger iD, Kirat Sandhu, Cara D Dolin, Antonio Bajan, Elizabeth Raiff, Justin R Lappen

American Journal of Perinatology · 2026-01 · 43 (02) · 272-274

DOI: 10.1055/a-2565-9272 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift American Journal of Perinatology, online erschienen am 30.04.2025. Verfasst von Adina R Kern-Goldberger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Obstetrics, Gynecology, and Women's Health Institute, Cleveland Clinic Foundation, Cleveland, Ohio. Hauptthemen laut MEDLINE: Aspirin, Pre-Eclampsia, Platelet Aggregation Inhibitors, Pregnancy, High-Risk. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low-dose aspirin is an established preventive strategy for reducing the risk of preeclampsia in patients with designated risk factors. This prospective observational study evaluated trends in aspirin prescription rates in a multihospital health system over a 10-month period during which a policy to offer low-dose aspirin universally was instituted. A total of 11,382 patients were included and an interrupted time series was used to analyze rates of aspirin prescriptions ordered by 16 weeks, before and after implementation of the universal policy. There were statistically significant increases in aspirin prescription rates for the entire cohort (incidence rate ratio [IRR]: 2.93; 95% confidence interval [CI]: 2.13–4.04) and for a high-risk subcohort including patients with chronic hypertension, pregestational diabetes, and/or multiple gestation (IRR: 1.48; 95% CI: 1.26–1.76). Instituting a policy to offer universal low dose aspirin during pregnancy resulted in significantly increased utilization among patients with high-risk indications for aspirin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinPre-EclampsiaPlatelet Aggregation InhibitorsPregnancy, High-RiskPractice Patterns, Physicians'HumansFemalePregnancyProspective StudiesAdultRisk FactorsInterrupted Time Series Analysis

Substanzen

AspirinPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Obstetrics, Gynecology, and Women's Health Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Department of Quantitative Health Sciences, Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, Cleveland, Ohio.

ORCID-Profile: Adina R Kern-Goldberger

Zitieren

APA

Kern-Goldberger, A. R., Sandhu, K., Dolin, C. D., Bajan, A., Raiff, E., & Lappen, J. R. (2026). The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients. American Journal of Perinatology, 43(02), 272-274. https://doi.org/10.1055/a-2565-9272

Vancouver

Kern-Goldberger AR, Sandhu K, Dolin CD, Bajan A, Raiff E, Lappen JR. The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients. American Journal of Perinatology. 2026;43(02):272-274. doi:10.1055/a-2565-9272

BibTeX
@article{KernGoldberger2026,
  author = {Kern-Goldberger, Adina R and Sandhu, Kirat and Dolin, Cara D and Bajan, Antonio and Raiff, Elizabeth and Lappen, Justin R},
  title = {The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients},
  journal = {American Journal of Perinatology},
  year = {2026},
  volume = {43},
  number = {02},
  pages = {272--274},
  doi = {10.1055/a-2565-9272}
}
Kostenlos starten →